Description

DNA repair drugs are used in repairing damaged DNA and for treating cancers. DNA damage can affect normal cell replicative function and impact rates of apoptosis. Alternatively, damage to genetic material can result in impaired cellular function, cell loss, or the transformation of healthy cells to cancers. The global DNA repair drugs market is poised to grow by US$ 45.5 billion during 2022-2028, progressing at a CAGR of 19.8% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for DNA repair drugs. The global DNA repair drugs market is segmented on the basis of application, and region. By application, the global DNA repair drugs market has been segmented into breast cancer, ovarian cancer. The breast cancer segment was the largest contributor to the global DNA repair drugs market in 2021. Geographically, the global DNA repair drugs market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). According to the research, North America had the largest share in the global DNA repair drugs market.

The global DNA repair drugs market is highly competitive. Key companies profiled in the report include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Eli Lilly and Company, Gilead Sciences Inc., GlaxoSmithKline plc (GSK), Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc., Roche Holding AG, Sanofi S.A., The Bristol-Myers Squibb Company (BMS).

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the DNA repair drugs market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Application: breast cancer, ovarian cancer
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global DNA repair drugs market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. DNA repair drugs market overview
Part 3. Market breakdown by application
– Breast cancer
– Ovarian cancer
Part 4. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 5. Key companies
– Abbott Laboratories
– AbbVie Inc.
– Amgen Inc.
– AstraZeneca plc
– Bayer AG
– Eli Lilly and Company
– Gilead Sciences, Inc.
– GlaxoSmithKline plc (GSK)
– Johnson & Johnson
– Merck KGaA
– Novartis AG
– Pfizer Inc.
– Roche Holding AG
– Sanofi S.A.
– The Bristol-Myers Squibb Company (BMS)
About StrategyHelix
Disclaimer